 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
 |
Pittsburgh, PA |
 |
09/23/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
 |
Los Angeles, CA Atlanta, GA New York, NY Houston, TX Salt Lake City, UT |
 |
08/11/2009 |
 |
 |
 |
Details |
 |
A Phase II Safety and Tolerability Study of Avastin When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain |
 |
West Palm Beach, FL Charlotte, NC Durham, NC |
 |
06/16/2009 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Randomized, Parallel Group, Multi-Centre Study in Recurrent Glioblastoma Subjects to Compare the Efficacy of AZD2171 [RECENTIN] Monotherapy and the Combination of AZD2171 with Lomustine to the Efficacy of Lomustine Alone |
 |
Cincinnati, OH |
 |
04/06/2009 |
 |
 |
 |
Details |
 |
Phase III, randomised, parallel Group, multi-centre study in recurrent glioblastoma patients to compare the efficacy of cediranib monotherapy and the combination of cediranib with lomustine to the efficacy of lomustine alone |
 |
Houston, TX |
 |
04/03/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Adults with High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas |
 |
Pittsburgh, PA |
 |
01/06/2009 |
 |
 |
 |
Details |
 |
Monteris AutoLITT™ FIM Safety Trial for Recurrent/Progressive Brain Tumors
|
 |
Cleveland, OH Cleveland, OH |
 |
11/19/2008 |
 |
 |
 |
 |
 |
Details |
 |
BIBW 2992 with or without daily temozolomide in the treatment of
patients with recurrent malignant glioma
|
 |
Charlottesville, VA |
 |
10/20/2008 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Charlottesville, VA |
 |
09/30/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Randomized Phase II Trial of Bevacizumab With Irinotecan or Bevacizumab With Temozolomide in Recurrent Glioblastoma
|
 |
Houston, TX |
 |
04/15/2008 |
 |
 |
 |
Details |
 |
Chemotherapy, Radiation Therapy, and Vaccine Therapy With or Without Daclizumab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery |
 |
Durham, NC |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
A phase I/II Evaluation of Vaccination with Type-1 Dendritic Cells Pulsed With Multiple Peptides In the Treatment of HLA-A2 Positive Patients With Recurrent Malignant Gliomas |
 |
Pittsburgh, PA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
 |
San Francisco, CA |
 |
10/03/2007 |
 |
 |
 |
 |
 |
Details |
 |
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor |
 |
Hamilton, Canada Perth, Western Australia, 6001, Australia Orange, CA Sacramento, CA Washington, DC St. Petersburg, FL West Palm Beach, FL Atlanta, GA Indianapolis, IN Kansas City, MO Charlotte, NC Paterson, NJ Summit, NJ New York, NY Columbus, OH Oklahoma City, OK Pittsburgh, PA San Antonio, TX Roanoke, VA Charleston, WV |
 |
08/18/2007 |
 |
 |
 |
Details |
 |
Phase I Study Of Pioglitazone And Isotretinoin In Patients With Recurrent Or Progressive Malignant Gliomas |
 |
Los Angeles, CA |
 |
08/18/2007 |
 |
 |
 |
 |
 |
Details |
 |
Open-label, Dose Confirmation and Dosimetry Study of Interstitial 131-I chTNT-1/B mAb (Cotara®) for the Treatment of Recurrent Glioblastoma Multiforme (GBM) |
 |
Tustin, CA |
 |
07/31/2007 |
 |
 |
 |
Details |
 |
A Pilot Study of Temozolomide and 06Benzylguanine for Treatment of Newly Diagnosed High Grade Glioma, Using Autologous Peripheral Blood Stem Cells Genetically Modified for Chemoprotection |
 |
Cincinnati , OH |
 |
05/01/2007 |
 |
 |
 |
 |
 |
Details |
 |
Methotrexate, Cyclophosphamide, and Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Dexamethasone and Cytarabine in Treating Patients With Primary CNS Lymphoma |
 |
Cleveland, OH Portland, OR |
 |
05/01/2007 |
 |
 |
 |
Details |
 |
Phase II Study of Erlotinib in Patients With Recurrent or Progressive Glioblastoma Multiforme
|
 |
Cleveland, OH |
 |
04/15/2007 |
 |
 |
 |
 |
 |
Details |
 |
TREATMENT OF NEWLY DIAGNOSED, HIGH-GRADE, MALIGNANT GLIOMA WITH POLIFEPROSAN 20 CONTAINING CARMUSTINE IMPLANT (GLIADEL® WAFER) USING MR SPECTROSCOPY DATA AS A PRIMARY INDICATOR OF THERAPEUTIC RESPONSE |
 |
New York, NY |
 |
10/12/2006 |
 |
 |
 |
Details |
 |
Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme |
 |
Scottsdale/Phoenix, AZ Jacksonville, FL Des Moines, IA Sioux City, IA Rochester, MN Saint Louis Park, MN Bismarck, ND Fargo, ND |
 |
06/26/2006 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
 |
Jacksonville, FL Jacksonville, FL Des Moines, IA Moline, IL Peoria, IL Urbana, IL Wichita, KS Lambertville, MI Rochester, MN Saint Louis Park, MN Billings, MT Bismarck, ND Lincoln, NE Danville, PA Spartanburg, SC Sioux Falls, SD |
 |
06/26/2006 |
 |
 |
 |
Details |
 |
Phase 3 study: Radiation Therapy and Combination Chemotherapy Followed by Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor |
 |
Durham, NC Memphis, TN Houston, TX |
 |
05/02/2006 |
 |
 |
 |
 |
 |
Details |
 |
A Pilot Study of Dronabinol for the treatment of nausea,vomiting and appetite loss in Adult Patients With Primary Gliomas |
 |
Durham, NC |
 |
05/01/2006 |
 |
 |
 |
Details |
 |
"Head Start" chemotherapy protocol for children less than 10 years old with newly diagnosed high grade primary brain tumors with intent to eliminate irradiation and abbreviate total duration of treatment to 6 months with resultant improved cure rate and quality of survival. |
 |
Oakland, CA |
 |
05/01/2006 |
 |
 |
 |
 |
 |